Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Latest news from Datamonitor

October 9, 2007 Research and Development

Critical Therapeutics starts Phase I trial of zileutonCritical Therapeutics has initiated a phase I clinical trial to assess the safety …
News

Wyeth buys Scottish biotech firm

October 8, 2007 Research and Development

Wyeth is to acquire Haptogen, a biotech research company based in Aberdeen which has a unique approach to targeting the …
News

Latest news from Datamonitor

October 1, 2007 Research and Development

Cubicin approved for marketing in CanadaCubist Pharmaceuticals has said that Health Canada has approved Cubicin for marketing in Canada, where …
News

Leukaemia drug enters phase III studies in MS

September 28, 2007 Research and Development

Patients with multiple sclerosis could benefit from a drug currently used to treat leukaemia, with late-stage trials now commencing.Discovered by …
News

BMS makes $430m biotech acquisition

September 27, 2007 Research and Development

Bristol-Myers Squibb has significantly advanced its strategy to move into biologics with the acquisition of US biotech Adnexus.The $430 million …
News

UK clinical trials: on the mend?

September 26, 2007 Research and Development UK, clinical trials, global, research

How clinical research is organised in the UK is essential to the success of Britain's pharma industry, and to the …
Feature

Pfizer’s Celsentri approved in Europe

September 25, 2007 Research and Development, Sales and Marketing HIV

Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …
News

Latest news from Datamonitor

September 17, 2007 Research and Development, Sales and Marketing

Cell Therapeutics launches Phase III study for pixantroneCell Therapeutics has launched its phase III clinical trial, known as PIX303, of …
News

UK stem-cell research to benefit from hybrid embryos decision

September 10, 2007 Research and Development stem cell

A new ruling on the use of hybrid human-animal embryos could help UK researchers extend their lead over European rivals.The …
News

Latest news from Datamonitor

September 10, 2007 Research and Development, Sales and Marketing

Akela reports positive results for Fentanyl Taifun trialAkela Pharma has reported promising results from a phase IIb trial for its …
News

AZ opens clinical pharmacology unit in China

September 6, 2007 Research and Development China, em

AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …
News

Pfizer and BMS to fight fat together

August 29, 2007 Research and Development

A new research collaboration between Pfizer and Bristol-Myers Squibb could eventually produce innovative treatments for metabolic diseases including obesity and …
News

Latest news from Datamonitor

August 28, 2007 Research and Development, Sales and Marketing

Alfacell reports promising results for cancer drugAlfacell Corporation has reported the results of a preclinical study showing that its cancer …
News

News roundup from Datamonitor

August 17, 2007 Research and Development, Sales and Marketing

Cel-Sci secures manufacturing facility for Multikine cancer drugCel-Sci has entered into an agreement with a biomedical real estate group under …
News

News from Datamonitor

August 13, 2007 Research and Development, Sales and Marketing

Alnylam lands $38.6 million federal government contractAlnylam Pharmaceuticals has been awarded a $38.6 million contract over 33 months from the …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026